Related Experiment Videos
Drug treatment of heart failure
1Department of Cardiac Medicine, National Heart and Lung Institute, London, United Kingdom.
Insights
Treating chronic heart failure aims to prevent occurrence, ease symptoms, and reduce mortality. Current guidelines suggest early use of angiotensin-converting enzyme inhibitors and diuretics for mild cases or left ventricular dysfunction.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Chronic heart failure (CHF) management involves multiple treatment objectives.
- Current therapeutic strategies are debated for mild CHF and left ventricular dysfunction.
Purpose of the Study:
- To summarize the treatment goals for chronic heart failure.
- To highlight the ongoing discussion regarding drug selection in specific patient populations.
Main Methods:
- Literature review of current treatment objectives and controversies in heart failure pharmacotherapy.
- Analysis of trends in the management of mild chronic heart failure.
Main Results:
- Key objectives include primary prevention, symptom alleviation, disease progression delay, and mortality reduction.
- A notable trend involves the early integration of angiotensin-converting enzyme inhibitors with diuretics.
Conclusions:
- Optimizing heart failure treatment requires addressing specific patient profiles.
- Early intervention with specific drug combinations may be beneficial for certain heart failure patients.
Abstract:
The objectives of treatment for patients with chronic heart failure are the prevention of the initial occurrence, the alleviation of signs and symptoms, the delay of the progression of damage to heart muscle and the reduction of the mortality rate. Many drugs are used in severe heart failure. Current controversy is concerned with which drugs to use in patients with mild heart failure or with left ventricular dysfunction. There is a trend towards the earlier introduction of an angiotensin-converting enzyme inhibitor combined with a diuretic.